Koyfin Home > Directory > Health Care > Rhythm Pharmaceuticals Inc > Preferred Equity

Rhythm Pharmaceuticals Inc Preferred Equity Chart (RYTM)

Rhythm Pharmaceuticals Inc annual/quarterly Preferred Equity from 2016 to 2017.
  • Rhythm Pharmaceuticals Inc Preferred Equity for the quarter ending September 09, 2017 was $81m a 50.63% increase of 41m year over year
  • Rhythm Pharmaceuticals Inc Preferred Equity for the last 12 months ending September 09, 2017 was $81m a 50.63% increase of 41m year over year
  • Rhythm Pharmaceuticals Inc Annual Preferred Equity for 2016 was $40m a 0.00% decrease of 0m from 2015
  • Rhythm Pharmaceuticals Inc Annual Preferred Equity for 2015 was $40m
Other Balance Sheet Metrics:
  • Rhythm Pharmaceuticals Inc Total Assets for the quarter ending September 09, 2018 was $278m a 45.37% increase of 126m year over year
  • Rhythm Pharmaceuticals Inc Other Liabilities for the quarter ending September 09, 2018 was $0m a 20.83% increase of 0m year over year
  • Rhythm Pharmaceuticals Inc Total Equity for the quarter ending September 09, 2018 was $270m a 46.30% increase of 125m year over year
View Chart On Koyfin

Quarterly RYTM Preferred Equity Data

09/2017$81m
06/2017$61m
03/2017$60m
12/2016$40m

Annual RYTM Preferred Equity Data

2016$40m
2015$40m